The Patent Finder

Slil Biomedical Corporation

Also on record
Records under this name other than patents Slil Biomedical Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Slil Biomedical Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,794,545Conformationally restricted polyamine analogs as disease therapies
Formerly held
Lapsed on the fee record
Ended Sep 21, 2016 · USPTO record
Lapsed on the fee recordEnded Sep 21, 2016USPTO record
US 6,649,587Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
Formerly held
Lapsed on the fee record
Ended Nov 18, 2015 · USPTO record
Lapsed on the fee recordEnded Nov 18, 2015USPTO record
US 7,279,502Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
Formerly held
Lapsed on the fee record
Ended Oct 9, 2015 · USPTO record
Lapsed on the fee recordEnded Oct 9, 2015USPTO record
US 7,186,825Conformationally restricted polyamine analogs as disease therapies
Formerly held
Lapsed on the fee record
Ended Mar 6, 2015 · USPTO record
Lapsed on the fee recordEnded Mar 6, 2015USPTO record
US 7,026,347Porphyrin-polyamine conjugates for cancer therapy
Formerly held
Lapsed on the fee record
Ended Apr 11, 2014 · USPTO record
Lapsed on the fee recordEnded Apr 11, 2014USPTO record
US 6,982,351Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
Formerly held
Lapsed on the fee record
Ended Jan 3, 2014 · USPTO record
Lapsed on the fee recordEnded Jan 3, 2014USPTO record
US 7,491,849Oligoamine compounds and derivatives thereof for cancer therapy
Formerly held
Lapsed on the fee record
Ended Feb 17, 2013 · USPTO record
Lapsed on the fee recordEnded Feb 17, 2013USPTO record
US 7,453,011Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
Formerly held
Lapsed on the fee record
Ended Nov 18, 2012 · USPTO record
Lapsed on the fee recordEnded Nov 18, 2012USPTO record
US 6,809,176Quinones as disease therapies
Formerly held
Lapsed on the fee record
Ended Oct 26, 2012 · USPTO record
Lapsed on the fee recordEnded Oct 26, 2012USPTO record
US 7,312,244Polyamine analog-amino acid conjugates useful as anticancer agents
Formerly held
Lapsed on the fee record
Ended Dec 25, 2011 · USPTO record
Lapsed on the fee recordEnded Dec 25, 2011USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited